Allergic Rhinitis AND Asthma — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Allergic Rhinitis AND Asthma.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Allergic Rhinitis AND Asthma and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Redfern JS, Smith MA A quarter-century of montelukast: clinical lessons for adult and pediatric asthma and allergic rhinitis care Curr Med Res Opin, 2026.PMID 42466635
[2]Liao CH, Chou AK, Wang LC, Chiang BL, et al. Distinct epidemiological patterns of allergic disease comorbidity across elementary school grades in Taiwan Pediatr Res, 2026.PMID 42457989
[3]Hou Y, Zhang Q, Xu X, Zhao G Effects of vitamin D levels and vitamin D supplementation on allergic diseases: an umbrella review Front Allergy, 2026.PMID 42445461
[4]Goh SLE, Yang JX, Kan SJ, Ricci V, et al. Evidence-to-Recommendation Framework for 2026 ACE Clinical Guideline on allergic rhinitis - diagnosis and management Singapore Med J, 2026.PMID 42434879
[5]Taube C, Greulich T, Böing S, Pfaar O, et al. Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany Clin Transl Allergy, 2026.PMID 42426834
[6]Li JN [Interpretation of Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines 2024-2025 Revision: guidelines on intranasal treatments] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2026.PMID 42420039
[7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Allergic Rhinitis AND Asthma and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Redfern JS, Smith MA A quarter-century of montelukast: clinical lessons for adult and pediatric asthma and allergic rhinitis care Curr Med Res Opin, 2026.PMID 42466635
[2]Liao CH, Chou AK, Wang LC, Chiang BL, et al. Distinct epidemiological patterns of allergic disease comorbidity across elementary school grades in Taiwan Pediatr Res, 2026.PMID 42457989
[3]Hou Y, Zhang Q, Xu X, Zhao G Effects of vitamin D levels and vitamin D supplementation on allergic diseases: an umbrella review Front Allergy, 2026.PMID 42445461
[4]Goh SLE, Yang JX, Kan SJ, Ricci V, et al. Evidence-to-Recommendation Framework for 2026 ACE Clinical Guideline on allergic rhinitis - diagnosis and management Singapore Med J, 2026.PMID 42434879
[5]Taube C, Greulich T, Böing S, Pfaar O, et al. Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany Clin Transl Allergy, 2026.PMID 42426834
[6]Li JN [Interpretation of Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines 2024-2025 Revision: guidelines on intranasal treatments] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2026.PMID 42420039
[7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922